Embedded Databricks capabilities accelerate healthcare supply chain analytics and AI workloads. Tecsys Inc.(TSX: TCS), a global leader in supply chain management solutions, today announced the launch of TecsysIQ™, a cloud-native intelligence layer that helps healthcare organizations unify fragmented data and deliver AI-powered insights across clinical, operational and financial systems. Built on the Databricks Data Intelligence […]

Media Invited to Test Drive the Only Florida-Built 4x4s and 6x6s at New Showroom In a bold expansion move that underscores its national dominance in the custom truck space,Apocalypse Manufacturingand its exclusive retailer,SoFlo Customs,are proud to announce the grand opening of their newestdealership and experience center in the heart of Tampa. Officially opened on June

TSX Symbol: WJX Wajax Corporation (“Wajax” or the “Corporation”) today announced the appointment of Michael Hachey as Chief Operating Officer of the Corporation effective June 2, 2025. Reporting to Iggy Domagalski, President and Chief Executive Officer, Mr. Hachey will oversee the Corporation's operations, with a focus on operational excellence and building organizational capabilities. Mr. Hachey

This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled “Caution Concerning Forward-Looking Statements” later in this news release. Bell Canada (“Bell” or the “Company”) today announced the commencement of separate offers (the “Offers”) to purchase for cash up to C$500,000,000 (the “Maximum Purchase

(NASDAQ:ASND), – Once-weekly TransCon CNP demonstrated significantly higher annualized growth velocity, the primary endpoint, compared to placebo – Multiple benefits beyond linear growth were observed compared to placebo, with a safety and tolerability profile similar to placebo – The FDA grants Priority Review designation for the evaluation of medicines that, if approved, would provide a

(NASDAQ:OPRT), Highlights strong momentum in driving profitable growth and delivering stockholder value Urges stockholders to vote “FOR“ Oportun's two highly qualified nominees – Raul Vazquez and Carlos Minetti – on the GREEN proxy card Launches VoteForOportun.com, providing additional information for stockholders SAN CARLOS, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven

(TSX:TSK),(OTC US:TSKFF),(Other OTC:TSKFF),(TSX:TSK-WT), NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 02, 2025 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company“) (TSX: TSK, OTCQX: TSKFF) is pleased to announce that as a result of strong investor demand, the Company has increased the maximum

(NasdaqGM:CCLD),(NasdaqGM:CCLDP),(NasdaqGM:CCLDO), Somerset, N.J., June 02, 2025 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, announced today that its Co-Chief Executive Officers have been invited to participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,”

(NASDAQ:PDSB), Median overall survival data in first-line recurrent/metastatic (1L r/m) HNSCC remains durable at 30.0 months with additional follow-up of ~4.5 months beyond the initial abstract HPV16-positive is the most rapidly increasing HNSCC in the US VERSATILE-003 is the only ongoing Phase 3 clinical trial exclusively addressing 1L r/m HPV16-positive HNSCC PRINCETON, N.J., June 02,

(NASDAQ:TGTX), NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will participate in the Jefferies Global Healthcare Conference, being held at the Marriott Marquis, in New York City on June 3-5, 2025. The fireside chat is scheduled to